AgeX Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has AgeX Therapeutics's balance sheet done over the years? Its assets were worth $11,965,000 last year, which is more than in the previous period. 55% of AgeX Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $6,607,000, which means an decrease by -68% compared compared to last year.

Debt to Assets

AgeX Therapeutics, Inc. (AMEX:AGE): Debt to assets
2017 9631000 1.31M 13.62%
2018 10671000 2.44M 22.87%
2019 7442000 4.82M 64.83%
2020 3925000 9.32M 237.48%
2021 3154000 15.02M 476.51%
2022 3241000 20.55M 634.25%
2023 11965000 6.60M 55.22%

AGE Balance Sheet (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
345K645K584K527K2.35M6.70M7.37M
Short term investments
0000000
Net receivables
57K4K25K326K363K131K107K
Inventory
0001000
Other current assets
352K1.80M1.62M1.43M1.33M1.01M111K
Total current assets
754K2.45M2.23M2.28M4.05M7.85M7.59M
Non-current assets:
Property, Plant and Equipment
00001.12M90K129K
Goodwill
0000000
Intangible assets
607K738K870K1.59M2.15M2.70M1.87M
Long term investments
10.60M50K50K50K000
Other non-current assets
0000111K19K35K
Total non-current assets
11.21M788K920K1.64M3.38M2.81M2.03M
Total assets
11.96M3.24M3.15M3.92M7.44M10.67M9.63M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
1070K275K283K317K180K
Short term debt
3.67M7.64M7.14M2.39M428K82K0
Total current liabilities
5.91M10.07M8.96M5.35M3.29M2.44M1.31M
Non-current liabilities:
Long term debt
693K10.47M6.06M3.9M1.52M00
Deferred tax
0000000
Other non-current liabilities
0-10.47M-6.06M3.9M-1.52M2.12M0
Total non-current liabilities
693K10.47M6.06M3.96M1.52M2.12M0
Total liabilities
6.60M20.55M15.02M9.32M4.82M2.44M1.31M
Data sourceData sourceData sourceData sourceData sourceData source